MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer



MedicineWorld.Org - Cancer - Breast Cancer - Treatment options in ductal carcinoma in situ (DCIS)
Your gateway to information on treatment options in ductal carcinoma in situ (dcis)

Treatment options in ductal carcinoma in situ (DCIS):

Treatment options in ductal carcinoma in situ (DCIS)   

             arcgba.gif
       Unlike lobular carcinoma in situ (LCIS), ductal carcinoma in situ (DCIS) is a precancerous condition. There are several treatment options available for ductal carcinoma in situ.

Breast conserving surgery
      Breast conserving surgery followed by radiation therapy to the affected breast is now the standard form of treatment for ductal carcinoma in situ. The chance of involvement of lymph nodes in ductal carcinoma in situ is very small, in the order of 1% to 2%, hence axillary lymph node dissection is not usually done in most cases.

Sentinel lymph node biopsy
      Sentinel lymph node is the first lymph node in the system of lymphatic drainage of the part of breast that is involved with breast cancer or ductal carcinoma in situ. The first draining lymph node can be identified by various techniques including.....
Click on the above link to read more on sentinel lymph node biopsy.

Risk factors for lymph node involvement
      The following factors may be associated with increased risk of involvement of
  axillary nodes and hence associated with increased risk of positive sentinel lymph node.....

Adjuvant radiation therapy for DCIS
      Omission of breast radiation after breast conservation surgery is associated with higher incidence of recurrence rate. This is true for both ductal carcinoma in situ and invasive breast cancer....
Click on the above link to read more on the adjuvant radiation therapy of DCIS

Adjuvant Tamoxifen treatment for DCIS
      Adjuvant therapy is not routinely advised for patients with ductal carcinoma in situ. However Tamoxifen has been shown to decrease the risk of secondary breast cancer in women with high risk of breast cancer including women with history of ductal carcinoma in situ Adjuvant therapy is not routinely advised for patients with ductal carcinoma in situ. However Tamoxifen has been shown to decrease the risk of secondary breast cancer in women with high risk of breast cancer including women with history of....
Click on the link above to read more on the adjuvant tamoxifen therapy of DCIS.
 


Treatment options in ductal carcinoma in situ (DCIS)

 
BREAST CANCER MAIN PAGE
Home| Breast cancer news | Common terms| Breast cancer treatment| Treatment by stage| Surgical treatment| Chemotherapy| Chemo drugs| Breast cancer symptoms| Mammogram and breast cancer screening| Doxorubicin| Cyclophosphamide| Methotrexate| Hormonal therapy| Radiation therapy| Monoclonal therapy| High dose chemotherapy| Recurrent breast cancer| Bisphosphonates | Pregnancy and breast cancer | Risk factors | Risk details | My risk | Comprehensive | Breast cancer statistics | African Americans | Ashkenazi | Asians | Hispanic | Men | Native Americans | Older women | Younger women | Pregnant women | BRCA
 


Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.